You just read:

ImmunoCellular Therapeutics Announces ICT-107 Phase II Data Abstract Accepted for Oral Presentation at the 2014 ASCO Annual Meeting

News provided by

ImmunoCellular Therapeutics, Ltd.

Apr 21, 2014, 04:00 ET